Diabetes Types, Drug Treatments, and Dietary Management
This paper provides an introductory overview of the major types of diabetes—Type 1, Type 2, and gestational—with a focus on the prevalence and management of Type 2 diabetes. It examines Humulin N (insulin isophane) as a common pharmacological treatment, explaining its mechanism, duration of action, and method of administration. The paper also addresses the role of diet in managing blood sugar levels and reducing obesity-related risks. Finally, it outlines both the short-term effects, such as hypoglycemia, and the long-term complications of Type 2 diabetes, including macrovascular disease, kidney failure, and vision loss, emphasizing how proper diet and drug therapy can mitigate these outcomes.
- Types of Diabetes: Overview of Type 1, Type 2, and gestational diabetes
- Drug Treatment for Type 2 Diabetes: Humulin N insulin therapy and administration method
- Dietary Considerations: Diet's role in managing blood sugar and weight
- Short-Term and Long-Term Impact of Type 2 Diabetes: Complications from hypoglycemia to macrovascular disease
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper moves logically from classification of disease types to pharmacological treatment, then to lifestyle management, and finally to health outcomes — creating a coherent clinical narrative.
- It grounds general claims in specific detail, such as naming Humulin N, explaining its duration of action (12–18 hours), and describing the KwikPen delivery method, which adds practical credibility.
- It connects diet and drug therapy to both short-term and long-term consequences, giving the paper a cause-and-effect structure that reinforces the importance of integrated management.
Key academic technique demonstrated
The paper demonstrates synthesis of source material across multiple disciplines — pharmacology, epidemiology, nutritional science, and medical history — to support a unified argument about holistic diabetes management. Each claim is paired with an appropriately cited source, showing how evidence from different fields can work together to build a coherent health sciences argument.
Structure breakdown
The paper is organized into four thematic sections: (1) a classification of diabetes types to establish context; (2) a focused look at pharmacological treatment for Type 2 diabetes; (3) dietary recommendations and their rationale; and (4) an assessment of short-term and long-term complications. This progression mirrors the structure of a clinical overview, moving from diagnosis to treatment to prognosis.
Types of Diabetes
There are various types of diabetes that can affect people of all ages. Type 1 diabetes is a condition in which a person's body does not produce enough insulin. It is also known as juvenile diabetes because it regularly occurs in children and young adults. Type 2 diabetes, by contrast, is a condition in which the body's cells do not respond appropriately to the insulin produced (Arcangelo & Peterson, 2006). Type 2 diabetes is the most common variant, accounting for roughly 9 out of every 10 cases, and typically develops later in life, around middle age.
Gestational diabetes occurs in pregnant women who have not previously been diagnosed with diabetes. Blood sugar levels rise during pregnancy, causing these women to experience this form of the condition. After pregnancy, gestational diabetes can develop into Type 2 diabetes and may also pose health risks for the child.
Drug Treatment for Type 2 Diabetes
Because Type 2 diabetes is the most prevalent form of the disease, numerous drugs are available to treat it. Obtaining these treatments requires a prescription and a formal diagnosis from a physician. Humulin N is one drug commonly used to treat Type 2 diabetes. It is a man-made form of insulin known as insulin isophane. Since insulin helps the body lower blood sugar levels, Humulin N performs this function as an intermediate-acting insulin that remains active for approximately 12 to 18 hours. It is injected using a syringe-type device called a KwikPen, which can be self-administered by the patient (Drugs.com, 2012). This is the most common form of drug administration for individuals managing this type of diabetes.
For more information on insulin formulations and their clinical applications, the Mayo Clinic's overview of Type 2 diabetes treatment provides a thorough reference for patients and caregivers.
References
Arcangelo, V. P., & Peterson, A. M. (Eds.). (2006). Pharmacotherapeutics for advanced practice: A practical approach (Vol. 536). Lippincott Williams & Wilkins.
Drugs.com. (2012). Retrieved from http://www.drugs.com/
Hruby, A., & Hu, F. B. (2015). The epidemiology of obesity: A big picture. Pharmacoeconomics, 33(7), 673–689.
Mohammedi, K., Woodward, M., Hirakawa, Y., Zoungas, S., Williams, B., Lisheng, L., ... & Marre, M. (2016). Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes. Diabetes Care, dc160588.
Moore, M. D. (2018). Food as medicine: Diet, diabetes management, and the patient in twentieth century Britain. Journal of the History of Medicine and Allied Sciences, 73(2), 150–167.
Always verify citation format against your institution’s current style guide requirements.